BioNexus Gene Lab Corporation Stock Other OTC
Equities
BGLC
US0906281086
Biotechnology & Medical Research
Sales 2022 | 10.93M 14.9M | Sales 2023 | 9.77M 13.32M | Capitalization | 9.36M 12.77M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -2M -2.73M | EV / Sales 2022 | 14.9 x |
Net cash position 2022 | 2.06M 2.81M | Net cash position 2023 | 5.78M 7.88M | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
-461
x | P/E ratio 2023 |
-3.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.63% |
Managers | Title | Age | Since |
---|---|---|---|
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Keong Yap
BRD | Director/Board Member | 68 | 22-03-06 |
Wei Foong Lim
BRD | Director/Board Member | 48 | 12-10 |
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.87B | |
-10.62% | 37.8B | |
+40.49% | 37.61B | |
+29.92% | 31.32B | |
-9.78% | 27.4B | |
+12.34% | 26.32B | |
+41.53% | 14.07B | |
+31.49% | 12.5B | |
-7.40% | 11.23B |